Concurrent Investment Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
5,524
-39
-0.7% -$6.88K 0.01% 1169
2026
Q1
$999K Buy
5,563
+1,014
+22% +$173K 0.01% 880
2025
Q4
$643K Sell
4,549
-1,621
-26% -$184K 0.01% 1037
2025
Q3
$500K Buy
6,170
+1,446
+31% +$112K 0.01% 910
2025
Q2
$296K Buy
4,724
+965
+26% +$57.1K 0.01% 1070
2025
Q1
$271K Buy
+3,759
New +$306K 0.01% 979
2024
Q4
– Sell
-2,350
Closed -$223K – 1125
2024
Q3
$223K Buy
2,350
+166
+8% +$14.7K 0.01% 898
2024
Q2
$209K Sell
2,184
-946
-30% -$112K 0.01% 865
2024
Q1
$412K Buy
3,130
+1,119
+56% +$138K 0.02% 596
2023
Q4
$291K Buy
+2,011
New +$276K 0.01% 661

Other funds holding ALB

Concurrent Investment Advisors's ALB Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Albemarle (ALB) stake by 0.7% in Q2 2026, selling an estimated $6.88K and leaving 5,524 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #1169.

Concurrent Investment Advisors first reported a position in ALB in Q4 2023 and has held it in 10 quarters since. The position peaked at $999K in Q1 2026. 945 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Concurrent Investment Advisors held 5,524 shares of Albemarle worth $746K as of Q2 2026.
  • Concurrent Investment Advisors sold 39 Albemarle shares in Q2 2026, an estimated $6.88K.
  • Albemarle made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1169 holding.
  • Concurrent Investment Advisors first reported a position in Albemarle in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Albemarle position peaked at $999K in Q1 2026.
  • 945 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.